For those that started filtering their lipid preparations, have you seen an increased incidence in line clotting? We have had several of our neonatal PICC lines clot off which is temporally related to filtering the Nutralipid preparation. They switched back to the Intralipid preparation and have not been filtering it and have not seen any further issues with line clotting. Before deciding if this is a product issue or a filtering issue I wanted to see what others have experienced?

Thank you,

Randi

How many of you practice in institution that primarily utilize SSI and how many of your institutions currently primarily utilize basal bolus insulin (BBI) regimens? If you primarily use BBI regimens, how did you implement and what types of outcomes are you having?

We are currently a primarily SSI driven institution but are exploring becoming more BBI driven.

Thanks,
Emily

How many of you practice in institution that primarily utilize SSI and how many of your institutions currently primarily utilize basal bolus insulin (BBI) regimens? If you primarily use BBI regimens, how did you implement and what types of outcomes are you having?

We are currently a primarily SSI driven institution but are exploring becoming more BBI driven.

Thanks,
Emily

I am wondering if there are best practice and/or standard concentrations used by neonatal units for UAC flush bags to maintain line patency. I am most familiar with hePARIN 0.5 units/mL and hePARIN 1 unit/mL but unsure if that is the standard of practice? Additionally, how do most facilities prepare this infusion? What hePARIN concentration product is used? Do you use the hePARIN IV flush syringe 500 units/5 mL syringe (100 units/mL 5 mL- classified as a device by FDA) or use hePARIN from another product(vial)? Do you add to prefilled NS or 0.45% saline bag or make exact volume?

Has anyone started working on "ensure all appropriate antidotes, etc." (Best Practice 9 of ISMP's Best Practices)? Or do you already have a good process in place?

I'm struggling with what type of "emergency administration" we would want to sanction.

Thanks!

Greetings!

One of our NICU pharmacists is asking pharmacy to draw up Albumin patient specific in IV room. Does anyone else have experience with drawing up albumin? If yes, can you please describe your process, and how do you clean up spills in IV room, since it’s a blood product.

Thank you

Greetings,

How many sites have approved this medication for use?

We approved the above medication for use in the cath lab. Since approval, we have struggled with ensuring that this medication is used properly in terms of giving Brilinta while patient is getting the infusion or start a med after the infusion is stopped. How are other sites dealing with this? We are an Epic facility and medication orders on a navigator tab.

Many thanks,
Carol Welch, Pharm.D., M.S.
MSO

I'm new to the forum, so I apologize now for flooding it with new, and likely pre-discussed topics. This morning, I am curious of institutions that have had success in eliminating Sterile Water liter bags from their facilities. I have made a couple of attempts at this and have been blocked by a "legitimate clinical need" for this product. Specifically for making Sodium Bicarbonate drips. Has anyone been successful in this action and if so, how did you overcome the "legitimate need" issue?

Has anyone seen an increase in anaphylaxis or allergic reactions with vincristine administration?

Hello all,

I am looking for any hospitals out there who have had experience with the implementation of the SAFER Guides. If you or your organization have used these to improve the safety of your information systems please reply to this message. Joan Ash and I are interested in your experience and may want to ask a few follow-up questions.

Thank you,